FNRAX | PGNAX | FNRAX / PGNAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 35 years | - |
Gain YTD | 7.559 | 4.576 | 165% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 1000 | 10,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 342M | 674M | 51% |
Annual Yield % from dividends | 1.78 | 1.78 | 100% |
Returns for 1 year | 13.14 | 9.60 | 137% |
Returns for 3 years | 36.02 | 18.57 | 194% |
Returns for 5 years | 62.26 | 87.84 | 71% |
Returns for 10 years | 1.80 | 26.35 | 7% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HERSX | 10.31 | -0.03 | -0.29% |
Hartford Emerging Markets Equity R4 | |||
WDIIX | 13.82 | -0.07 | -0.50% |
Wilmington Enhanced Div Inc Strat I | |||
CSMEX | 27.06 | -0.15 | -0.55% |
Carillon Scout Mid Cap A | |||
GSILX | 20.73 | -0.16 | -0.77% |
Goldman Sachs GQG Ptnrs Intl Opps C | |||
ETHSX | 13.85 | -0.34 | -2.40% |
Eaton Vance Worldwide Health Sci A |